Condition : Psoriasis, Arthritic Interventions : Drug: ixekizumab; Drug: Placebo; Drug: Adalimumab Sponsor : Eli Lilly and Company Recruiting - verified February 2014

Condition : Psoriasis, Arthritic Interventions : Drug: ixekizumab; Drug: Placebo; Drug: Adalimumab Sponsor : Eli Lilly and Company Recruiting - verified November 2013

Condition : Psoriasis, Arthritic Interventions : Drug: ixekizumab; Drug: Placebo; Drug: Adalimumab Sponsors : Eli Lilly and Company; Eli Lilly and Company Recruiting - verified September 2013

Condition : Psoriatic Arthritis (PsA) Intervention : Other: Intensive Care Sponsors : Pope Research Corporation; Amgen Recruiting - verified November 2013

Conditions : Psoriasis; Psoriatic Arthritis Interventions : Drug: Apremilast tablet/pill 30 mg; Drug: Etanercept 50 mg; Drug: Placebo tablet; Drug: Placebo injection (saline) Sponsor : Celgene Corpora...

Conditions : Psoriasis; Psoriatic Arthritis Interventions : Drug: Apremilast 30 mg; Drug: Etanercept 50 mg; Drug: Placebo tablet; Drug: Placebo injection (saline) Sponsors : Celgene Corporation; Celge...

Condition : Ankylosing Spondylitis Intervention : Other: stretching exercise Sponsor : University of Sao Paulo Completed - verified February 2014

Condition : Arthritis, Rheumatoid Interventions : Drug: Sirukumab 100 mg; Drug: Sirukumab 50 mg; Drug: Placebo Sponsors : Janssen Pharmaceutical K.K.; GlaxoSmithKline, PLC Recruiting - verified Novemb...

Condition : Patients With Anti-CCP Positive Early Rheumatoid Arthritis Intervention : Other: Periodontal prophylaxis Sponsors : Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux...

Condition : Rheumatoid Arthritis (RA) Interventions : Other: non-interventional study; Other: non-interventional study; Other: non-interventional study; Other: non-interventional study Sponsors : Pfiz...